US Stock MarketDetailed Quotes

United Therapeutics (UTHR)

Watchlist
  • 568.580
  • -7.210-1.25%
Close May 15 16:00 ET
  • 568.580
  • 0.0000.00%
Post 16:04 ET
24.13BMarket Cap21.02P/E (TTM)

United Therapeutics (UTHR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
0.46%463.3M
17.64%1.56B
1.47%346.2M
49.02%562.1M
-17.44%191.7M
22.50%461.2M
35.70%1.33B
126.41%341.2M
8.95%377.2M
118.44%232.2M
Net income from continuing operations
-14.68%274.9M
11.68%1.33B
20.91%364.3M
9.58%338.7M
11.29%309.5M
5.09%322.2M
21.35%1.2B
38.78%301.3M
15.51%309.1M
7.29%278.1M
Operating gains losses
1,062.26%61.6M
----
----
----
----
--5.3M
----
----
----
----
Depreciation and amortization
14.14%22.6M
18.07%85.6M
15.74%22.8M
14.66%21.9M
12.83%21.1M
32.00%19.8M
36.28%72.5M
43.80%19.7M
43.61%19.1M
44.96%18.7M
Deferred tax
--25.9M
252.42%97.7M
----
----
----
--0
0.47%-64.1M
----
----
----
Other non cash items
680.49%32M
18.93%-19.7M
-1,192.31%-33.6M
98.25%-100K
280.00%9.9M
139.05%4.1M
-395.92%-24.3M
48.00%-2.6M
-216.67%-5.7M
-41.03%-5.5M
Change In working capital
-84.10%12.4M
-2,830.77%-106.5M
-340.40%-144M
1,150.00%162.5M
-86.58%-203M
95.98%78M
111.68%3.9M
319.41%59.9M
-71.74%13M
39.32%-108.8M
-Change in receivables
189.46%38.2M
-17,625.00%-70.9M
-184.00%-52.5M
259.69%81.6M
-447.27%-57.3M
-50.88%-42.7M
99.32%-400K
407.88%62.5M
-465.00%-51.1M
111.95%16.5M
-Change in inventory
-258.04%-40.1M
-12.15%-52.6M
-42.24%-16.5M
-54.87%-17.5M
49.66%-7.4M
-20.43%-11.2M
-244.85%-46.9M
-65.71%-11.6M
-264.52%-11.3M
-1,370.00%-14.7M
-Change in payables and accrued expense
-388.46%-12.7M
129.27%97.9M
228.89%23.2M
-5.45%31.2M
78.68%46.1M
-236.84%-2.6M
-25.22%42.7M
22.08%-18M
-16.24%33M
-32.11%25.8M
-Change in other working capital
-79.93%27M
-1,051.76%-80.9M
-463.70%-98.2M
58.49%67.2M
-35.19%-184.4M
78.15%134.5M
146.20%8.5M
16.88%27M
1,086.05%42.4M
-74.42%-136.4M
Cash from discontinued investing activities
Operating cash flow
0.46%463.3M
17.64%1.56B
1.47%346.2M
49.02%562.1M
-17.44%191.7M
22.50%461.2M
35.70%1.33B
126.41%341.2M
8.95%377.2M
118.44%232.2M
Investing cash flow
Cash flow from continuing investing activities
551.55%743.7M
-232.14%-551.3M
-84.74%-227.6M
222.63%140.9M
-274.88%-299.9M
-122.40%-164.7M
157.98%417.2M
-392.64%-123.2M
63.34%-114.9M
64.79%-80M
Net PPE purchase and sale
-34.58%-100.8M
-111.16%-520.5M
-99.42%-172.9M
-175.16%-210.5M
-37.92%-62.2M
-96.07%-74.9M
-6.99%-246.5M
-10.17%-86.7M
-16.44%-76.5M
-0.89%-45.1M
Net intangibles purchase and sale
----
---5.5M
--0
----
----
----
--0
--0
----
----
Net business purchase and sale
---25M
-80.33%-55M
16.67%-25M
---30M
--0
--0
65.81%-30.5M
66.37%-30M
--0
----
Net investment purchase and sale
1,185.86%875.2M
-94.45%40.1M
-6,860.00%-34.8M
2,005.83%392.6M
-597.35%-237.1M
-110.36%-80.6M
291.70%722.7M
-100.23%-500K
91.31%-20.6M
80.98%-34M
Net other investing changes
38.04%-5.7M
63.51%-10.4M
185.00%5.1M
67.98%-5.7M
-50.00%-600K
-113.95%-9.2M
-23.91%-28.5M
31.03%-6M
-67.92%-17.8M
---400K
Cash from discontinued investing activities
Investing cash flow
551.55%743.7M
-232.14%-551.3M
-84.74%-227.6M
222.63%140.9M
-274.88%-299.9M
-122.40%-164.7M
157.98%417.2M
-392.64%-123.2M
63.34%-114.9M
64.79%-80M
Financing cash flow
Cash flow from continuing financing activities
-1,482.52%-1.48B
8.35%-1.15B
231.73%98.4M
-1,391.42%-956M
-313.75%-198.6M
91.22%-93.8M
-10,444.54%-1.25B
19.50%-74.7M
-943.42%-64.1M
-294.33%-48M
Net issuance payments of debt
--0
25.00%-300M
--0
--0
-100.00%-200M
0.00%-100M
-300.00%-400M
0.00%-100M
---100M
---100M
Net common stock issuance
---1.5B
-0.43%-1.02B
1,566.67%4.4M
-250,025.00%-1B
-78.26%-20.5M
--0
-7,234.78%-1.01B
-200.00%-300K
-100.00%-400K
14.81%-11.5M
Proceeds from stock option exercised by employees
243.72%73.9M
14.37%183.1M
286.72%99M
22.59%44.5M
-65.26%18.1M
-53.36%21.5M
53.06%160.1M
250.68%25.6M
365.38%36.3M
110.93%52.1M
Net other financing activities
-281.05%-58.3M
-511.11%-16.5M
---5M
--0
-66.67%3.8M
-8.51%-15.3M
0.00%-2.7M
--0
--0
-15.56%11.4M
Cash from discontinued financing activities
Financing cash flow
-1,482.52%-1.48B
8.35%-1.15B
231.73%98.4M
-1,391.42%-956M
-313.75%-198.6M
91.22%-93.8M
-10,444.54%-1.25B
19.50%-74.7M
-943.42%-64.1M
-294.33%-48M
Net cash flow
Beginning cash position
-8.25%1.56B
40.53%1.7B
-13.76%1.34B
17.51%1.59B
51.81%1.9B
40.53%1.7B
25.65%1.21B
40.28%1.55B
27.02%1.36B
7.56%1.25B
Current changes in cash
-236.85%-277.4M
-128.62%-140.1M
51.43%217M
-227.65%-253M
-394.43%-306.8M
362.79%202.7M
98.58%489.5M
43.30%143.3M
390.59%198.2M
208.32%104.2M
End cash Position
-32.64%1.28B
-8.25%1.56B
-8.25%1.56B
-13.76%1.34B
17.51%1.59B
51.81%1.9B
40.53%1.7B
40.53%1.7B
40.28%1.55B
27.02%1.36B
Free cash flow
-6.16%362.5M
-4.20%1.04B
-31.91%173.3M
15.10%346.1M
-30.79%129.5M
14.19%386.3M
44.54%1.08B
253.47%254.5M
7.20%300.7M
203.73%187.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 0.46%463.3M17.64%1.56B1.47%346.2M49.02%562.1M-17.44%191.7M22.50%461.2M35.70%1.33B126.41%341.2M8.95%377.2M118.44%232.2M
Net income from continuing operations -14.68%274.9M11.68%1.33B20.91%364.3M9.58%338.7M11.29%309.5M5.09%322.2M21.35%1.2B38.78%301.3M15.51%309.1M7.29%278.1M
Operating gains losses 1,062.26%61.6M------------------5.3M----------------
Depreciation and amortization 14.14%22.6M18.07%85.6M15.74%22.8M14.66%21.9M12.83%21.1M32.00%19.8M36.28%72.5M43.80%19.7M43.61%19.1M44.96%18.7M
Deferred tax --25.9M252.42%97.7M--------------00.47%-64.1M------------
Other non cash items 680.49%32M18.93%-19.7M-1,192.31%-33.6M98.25%-100K280.00%9.9M139.05%4.1M-395.92%-24.3M48.00%-2.6M-216.67%-5.7M-41.03%-5.5M
Change In working capital -84.10%12.4M-2,830.77%-106.5M-340.40%-144M1,150.00%162.5M-86.58%-203M95.98%78M111.68%3.9M319.41%59.9M-71.74%13M39.32%-108.8M
-Change in receivables 189.46%38.2M-17,625.00%-70.9M-184.00%-52.5M259.69%81.6M-447.27%-57.3M-50.88%-42.7M99.32%-400K407.88%62.5M-465.00%-51.1M111.95%16.5M
-Change in inventory -258.04%-40.1M-12.15%-52.6M-42.24%-16.5M-54.87%-17.5M49.66%-7.4M-20.43%-11.2M-244.85%-46.9M-65.71%-11.6M-264.52%-11.3M-1,370.00%-14.7M
-Change in payables and accrued expense -388.46%-12.7M129.27%97.9M228.89%23.2M-5.45%31.2M78.68%46.1M-236.84%-2.6M-25.22%42.7M22.08%-18M-16.24%33M-32.11%25.8M
-Change in other working capital -79.93%27M-1,051.76%-80.9M-463.70%-98.2M58.49%67.2M-35.19%-184.4M78.15%134.5M146.20%8.5M16.88%27M1,086.05%42.4M-74.42%-136.4M
Cash from discontinued investing activities
Operating cash flow 0.46%463.3M17.64%1.56B1.47%346.2M49.02%562.1M-17.44%191.7M22.50%461.2M35.70%1.33B126.41%341.2M8.95%377.2M118.44%232.2M
Investing cash flow
Cash flow from continuing investing activities 551.55%743.7M-232.14%-551.3M-84.74%-227.6M222.63%140.9M-274.88%-299.9M-122.40%-164.7M157.98%417.2M-392.64%-123.2M63.34%-114.9M64.79%-80M
Net PPE purchase and sale -34.58%-100.8M-111.16%-520.5M-99.42%-172.9M-175.16%-210.5M-37.92%-62.2M-96.07%-74.9M-6.99%-246.5M-10.17%-86.7M-16.44%-76.5M-0.89%-45.1M
Net intangibles purchase and sale -------5.5M--0--------------0--0--------
Net business purchase and sale ---25M-80.33%-55M16.67%-25M---30M--0--065.81%-30.5M66.37%-30M--0----
Net investment purchase and sale 1,185.86%875.2M-94.45%40.1M-6,860.00%-34.8M2,005.83%392.6M-597.35%-237.1M-110.36%-80.6M291.70%722.7M-100.23%-500K91.31%-20.6M80.98%-34M
Net other investing changes 38.04%-5.7M63.51%-10.4M185.00%5.1M67.98%-5.7M-50.00%-600K-113.95%-9.2M-23.91%-28.5M31.03%-6M-67.92%-17.8M---400K
Cash from discontinued investing activities
Investing cash flow 551.55%743.7M-232.14%-551.3M-84.74%-227.6M222.63%140.9M-274.88%-299.9M-122.40%-164.7M157.98%417.2M-392.64%-123.2M63.34%-114.9M64.79%-80M
Financing cash flow
Cash flow from continuing financing activities -1,482.52%-1.48B8.35%-1.15B231.73%98.4M-1,391.42%-956M-313.75%-198.6M91.22%-93.8M-10,444.54%-1.25B19.50%-74.7M-943.42%-64.1M-294.33%-48M
Net issuance payments of debt --025.00%-300M--0--0-100.00%-200M0.00%-100M-300.00%-400M0.00%-100M---100M---100M
Net common stock issuance ---1.5B-0.43%-1.02B1,566.67%4.4M-250,025.00%-1B-78.26%-20.5M--0-7,234.78%-1.01B-200.00%-300K-100.00%-400K14.81%-11.5M
Proceeds from stock option exercised by employees 243.72%73.9M14.37%183.1M286.72%99M22.59%44.5M-65.26%18.1M-53.36%21.5M53.06%160.1M250.68%25.6M365.38%36.3M110.93%52.1M
Net other financing activities -281.05%-58.3M-511.11%-16.5M---5M--0-66.67%3.8M-8.51%-15.3M0.00%-2.7M--0--0-15.56%11.4M
Cash from discontinued financing activities
Financing cash flow -1,482.52%-1.48B8.35%-1.15B231.73%98.4M-1,391.42%-956M-313.75%-198.6M91.22%-93.8M-10,444.54%-1.25B19.50%-74.7M-943.42%-64.1M-294.33%-48M
Net cash flow
Beginning cash position -8.25%1.56B40.53%1.7B-13.76%1.34B17.51%1.59B51.81%1.9B40.53%1.7B25.65%1.21B40.28%1.55B27.02%1.36B7.56%1.25B
Current changes in cash -236.85%-277.4M-128.62%-140.1M51.43%217M-227.65%-253M-394.43%-306.8M362.79%202.7M98.58%489.5M43.30%143.3M390.59%198.2M208.32%104.2M
End cash Position -32.64%1.28B-8.25%1.56B-8.25%1.56B-13.76%1.34B17.51%1.59B51.81%1.9B40.53%1.7B40.53%1.7B40.28%1.55B27.02%1.36B
Free cash flow -6.16%362.5M-4.20%1.04B-31.91%173.3M15.10%346.1M-30.79%129.5M14.19%386.3M44.54%1.08B253.47%254.5M7.20%300.7M203.73%187.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More